Next Article in Journal
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
Previous Article in Journal
Assessment of Patient-Reported Outcomes at 48 Months of Treatment with Dupilumab for Severe Atopic Dermatitis: A Single-Center Real-Life Experience with 126 Patients
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(1), 118; https://doi.org/10.3390/ph17010118
Action Date Notes Link
article xml file uploaded 16 January 2024 12:54 CET Original file -
article xml uploaded. 16 January 2024 12:54 CET Update https://www.mdpi.com/1424-8247/17/1/118/xml
article pdf uploaded. 16 January 2024 12:54 CET Version of Record https://www.mdpi.com/1424-8247/17/1/118/pdf
article html file updated 16 January 2024 12:55 CET Original file https://www.mdpi.com/1424-8247/17/1/118/html
Back to TopTop